“…A further use of mutants has been the elucidation of metabolic pathways. This has been exploited for the biosynthesis of tetracyclines (McCormick, 1965), novobiocin (Kominek, 1972), erythromycin (Martin et al, 1966;Martin & Rosenbrook, 1967), neomycin (Pearce et al, 1978), tylosin , other aminoglycosides (Penzikova & Levitov M, 1970;Takeda et al, 1978;Fujiwara et al, 1980;Kase et al, 1982;Hanssen & Kirby, 1983), rosaramicin (Vaughn et al, 1982), daunorubicin (McGuire et al, 1981, other anthracyclines Yue et al, 1986), actinomycin (Troost & Katz, 1979), carbapenems (Nozaki et al, 1984;Kojima et al, 1988), ansamycins (Kibby et al, 1980;Ghisalba et al, 1981), patulin (Gaucher et al, 1981 and phenazines (Byng et al, 1979).…”